Adamas Pharmaceuticals, Inc. logo

Adamas Pharmaceuticals, Inc. ADMS

$ 8.22 0.0%

Country

usaUSA

IPO year

2014

Industry

Drug manufacturers

Stock Exchange

NASDAQ GLOBAL

CEO

Mr. Neil McFarlane

Employees in the company

136

Shares

27.7 M

Market Cap[1]

$ 376 M

EBITDA (LTM)

$ -31.9 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.